Prescription Required
Formulation: Tablet
Prescription Required
Formulation: Tablet
(Generic Alternative)
Select the prescribed dosage
Select the quantity to see the price.
* This price includes a dispensing fee, medical review fee, and packing fee.
Shipped and delivered directly to your doorstep
Glyset (miglitol) is a prescription oral medication used to help control blood sugar levels in adults with type 2 diabetes mellitus.
Type 2 diabetes is a chronic condition that develops when the body does not respond properly to insulin or cannot produce enough insulin to maintain normal blood sugar levels.
Insulin is a hormone that helps glucose (sugar) move from the bloodstream into the body’s cells, where it is used for energy.
When insulin does not work effectively, glucose builds up in the bloodstream, causing high blood sugar levels. Over time, uncontrolled blood sugar can damage blood vessels, nerves, kidneys, and eyes.
Glyset contains miglitol, an active ingredient belonging to a class of medications called alpha-glucosidase inhibitors.
These medications work by slowing the digestion of carbohydrates in the small intestine. This helps reduce the rapid increase in blood sugar that usually occurs after eating.
Glyset is taken by mouth at the beginning of a meal, with the first bite of food. It is generally prescribed as part of a diabetes management plan that includes a balanced diet and regular physical activity.
Glyset is indicated to improve blood sugar control in adults with type 2 diabetes mellitus, particularly by reducing blood sugar increases after meals.
When you eat foods containing carbohydrates, your digestive system breaks them down into smaller sugars, including glucose.
Glucose then passes through the intestinal wall and enters your bloodstream.
In people with type 2 diabetes, the body may have difficulty using insulin effectively. As a result, blood sugar levels may rise higher than normal, especially after meals.
These increases are called postprandial blood glucose spikes.
Glyset helps control these spikes by slowing the breakdown and absorption of carbohydrates.
The medication may provide several benefits:
Glyset does not cure type 2 diabetes or reverse insulin resistance.
Instead, it helps manage blood glucose levels when used consistently with meals and alongside other recommended diabetes treatments.
Your healthcare provider may recommend regular blood glucose monitoring and HbA1c testing to assess how well the medication is working.
Glyset contains miglitol, an alpha-glucosidase inhibitor that slows the digestion of carbohydrates in the small intestine.
Carbohydrates are found in foods such as bread, rice, pasta, potatoes, fruits, and certain sweets.
During digestion, the body uses enzymes to break down complex carbohydrates into smaller sugar molecules.
One group of enzymes, called alpha-glucosidases, is located along the lining of the small intestine.
These enzymes help convert certain carbohydrates into simple sugars, including glucose, that can enter the bloodstream.
Miglitol temporarily blocks the activity of these enzymes.
As a result, carbohydrate digestion occurs more slowly, and glucose enters the bloodstream at a slower rate.
Slows Carbohydrate Digestion
When you eat carbohydrates, digestive enzymes break them down into sugars that the body can absorb.
Glyset inhibits alpha-glucosidase enzymes in the small intestine, delaying the final stages of carbohydrate digestion.
This means glucose from many carbohydrate-containing foods becomes available for absorption more gradually.
The medication does not prevent all carbohydrate absorption or completely block sugar from entering the bloodstream.
Instead, it helps slow the process, reducing the rapid rise in blood glucose after meals.
Reduces Blood Sugar Spikes After Meals
Blood glucose levels naturally increase after eating.
However, in people with type 2 diabetes, these increases may be greater or last longer because insulin does not work effectively.
By slowing carbohydrate digestion, Glyset helps reduce the size of blood sugar spikes after meals.
This effect is especially useful for people who have difficulty controlling their postprandial blood glucose levels.
Glyset mainly affects the blood sugar response to meals rather than directly lowering glucose production by the liver.
Does Not Directly Increase Insulin Production
Some diabetes medications lower blood sugar by encouraging the pancreas to release more insulin.
Glyset works differently.
Miglitol does not directly stimulate insulin secretion from the pancreas.
Instead, it slows carbohydrate digestion and reduces how quickly glucose becomes available for absorption.
Because of this mechanism, Glyset used alone generally has a low risk of causing hypoglycemia, or low blood sugar.
However, the risk increases when Glyset is combined with certain diabetes medications, particularly insulin or sulfonylureas.
Supports Long-Term Blood Sugar Management
Controlling blood sugar levels throughout the day is an important part of managing type 2 diabetes.
Frequent increases in after-meal glucose may contribute to elevated HbA1c levels.
Glyset helps manage these increases by slowing carbohydrate digestion during meals.
When combined with an appropriate meal plan, physical activity, and other prescribed treatments, Glyset may improve overall blood sugar control.
However, its effectiveness depends on the amount and type of carbohydrates consumed, medication adherence, and individual response to treatment.
Glyset begins working during the meal with which it is taken.
Miglitol acts in the small intestine to slow carbohydrate digestion and reduce the rise in blood sugar after eating.
Because Glyset works directly on carbohydrate digestion, its effects on after-meal blood glucose can begin with the first dose.
However, improvements in your overall diabetes control may take longer to measure.
Your healthcare provider may recommend checking your blood sugar approximately one hour after meals to assess how well the medication is working.
HbA1c levels are generally evaluated over several months because this test reflects average blood sugar levels over approximately two to three months.
Your healthcare provider may adjust your dosage based on your blood glucose readings, HbA1c results, and tolerance to treatment.
Glyset is usually taken three times daily, with the first bite of each main meal.
The usual starting dose is 25 mg three times daily, although your healthcare provider may recommend starting with fewer daily doses to reduce digestive side effects.
Common side effects include gas, bloating, abdominal discomfort, and diarrhea. These occur because some carbohydrates remain undigested for longer and are broken down by bacteria in the large intestine.
Glyset should not be used by people with certain serious intestinal conditions, including inflammatory bowel disease, intestinal obstruction, or chronic conditions that significantly affect digestion and absorption.
Although Glyset alone has a low risk of causing hypoglycemia, combining it with insulin or certain other diabetes medications may increase this risk.
If low blood sugar occurs while taking Glyset, use glucose (dextrose) rather than ordinary table sugar (sucrose) to raise your blood sugar. Miglitol slows the digestion of sucrose, making it less suitable for quickly treating hypoglycemia.
Glyset helps manage type 2 diabetes by slowing carbohydrate digestion and reducing blood sugar spikes after meals. When combined with a balanced diet, regular physical activity, and other prescribed treatments, it can help improve long-term blood sugar control.
Glyset is a prescription oral medication used to help control blood sugar levels in adults with type 2 diabetes.
Glyset belongs to a class of medications called alpha-glucosidase inhibitors. It works by slowing the breakdown of carbohydrates in the small intestine, helping reduce the rise in blood sugar levels after meals.
Glyset is available as oral tablets in strengths of 25 mg, 50 mg, and 100 mg.
The medication is usually taken three times daily, with the first bite of each main meal.
Your healthcare provider will determine the appropriate dosage based on your blood sugar levels, kidney function, response to treatment, and tolerance to side effects.
Follow these steps to take Glyset correctly and safely:
Do not take extra Glyset tablets to compensate for missed meals or higher carbohydrate intake.
The recommended dosage of Glyset depends on your individual blood sugar control and how well you tolerate the medication.
| Dosage information | General instructions |
| Dosage form | Oral tablet |
| Available strengths | 25 mg, 50 mg, and 100 mg |
| Usual starting dose | 25 mg three times daily |
| When to take | With the first bite of each main meal |
| Usual maintenance dose | 50 mg three times daily |
| Maximum recommended dose | 100 mg three times daily |
| Dosage adjustments | Based on blood glucose response, tolerance, and kidney function |
Your healthcare provider may begin treatment with a lower frequency, such as 25 mg once daily, before gradually increasing to three times daily.
Starting with a lower dose may help reduce gastrointestinal side effects, including gas, bloating, and diarrhea.
After several weeks, your healthcare provider may increase the dosage if additional blood sugar control is needed.
The maximum recommended dosage is 100 mg three times daily, although not everyone requires or tolerates this amount.
Do not increase your Glyset dosage without consulting your healthcare provider.
Take Glyset With the First Bite of Each Meal
Glyset works by slowing the enzymes responsible for breaking down carbohydrates into absorbable sugars.
These enzymes are active during digestion, making the timing of your medication important.
Taking Glyset with the first bite of food allows it to act while carbohydrates are being digested in the small intestine.
If you take Glyset too long before eating or after finishing your meal, it may not provide the intended effect on after-meal blood sugar levels.
For best results, take your prescribed dose when you begin eating each main meal.
If you skip a meal, generally skip the Glyset dose associated with that meal.
Do not take an extra tablet with your next meal to make up for the missed dose.
Follow Your Prescribed Dosage Schedule
Glyset is commonly prescribed three times daily because its effects are linked to carbohydrate digestion during meals.
Taking the medication consistently helps reduce repeated increases in after-meal blood sugar.
Your healthcare provider may adjust the dosage gradually based on your blood glucose readings and tolerance to treatment.
Do not take more Glyset than prescribed, even if your blood sugar is higher than expected.
Taking extra tablets may increase digestive side effects without providing the intended additional benefit.
If your blood sugar remains consistently above your target range, contact your healthcare provider for a treatment review.
Monitor Your Blood Sugar Regularly
Regular blood glucose monitoring is an important part of managing type 2 diabetes.
Glyset primarily reduces blood sugar increases after meals, so your healthcare provider may recommend checking your glucose levels at specific times.
These may include fasting blood glucose measurements and readings taken after meals.
Your healthcare provider may also recommend HbA1c testing every few months to assess your average blood sugar levels.
Blood sugar monitoring helps determine whether Glyset is working effectively or whether your treatment plan needs adjustment.
Keep a record of your glucose readings if recommended by your healthcare provider.
Watch for Digestive Side Effects
Glyset commonly causes gastrointestinal side effects, especially during the first few weeks of treatment.
Because miglitol slows carbohydrate digestion, some carbohydrates may reach the large intestine before being fully broken down.
Bacteria in the large intestine can ferment these carbohydrates, producing gas and other digestive symptoms.
Common side effects include flatulence, bloating, abdominal discomfort, and diarrhea.
These symptoms may become less noticeable as your body adjusts to treatment.
Starting at a lower dose and increasing gradually may improve tolerability.
Contact your healthcare provider if digestive symptoms become severe, persistent, or interfere with your daily activities.
Consider Your Kidney Function
Kidney function is an important consideration when taking Glyset.
Miglitol is absorbed into the bloodstream and eliminated primarily through the kidneys.
People with impaired kidney function may have higher medication levels because their bodies cannot eliminate miglitol as efficiently.
Glyset is generally not recommended for people with significant kidney impairment, particularly when creatinine clearance is below 25 mL/min.
Your healthcare provider may assess your kidney function before prescribing Glyset and during treatment when appropriate.
Tell your healthcare provider if you have kidney disease or a history of reduced kidney function.
If you forget to take Glyset with the first bite of a meal, do not take an extra dose later to make up for it.
Skip the missed dose and take your next scheduled dose with the first bite of your next main meal.
Do not double your dosage.
Glyset works during carbohydrate digestion, so taking a missed dose long after finishing a meal may not provide the intended benefit.
If you frequently miss doses or are unsure how to manage your medication schedule, contact your healthcare provider or pharmacist.
Glyset used alone has a low risk of causing hypoglycemia because it does not directly stimulate insulin production.
However, low blood sugar may occur when Glyset is used with insulin or certain other diabetes medications, particularly sulfonylureas.
Symptoms of hypoglycemia may include shaking, sweating, dizziness, hunger, headache, confusion, and a rapid heartbeat.
If hypoglycemia occurs while taking Glyset, use glucose (dextrose) to raise your blood sugar rather than ordinary table sugar (sucrose).
Glyset slows the breakdown of sucrose, which may delay its ability to increase blood sugar.
Glucose tablets or glucose gel containing dextrose are more appropriate options.
Follow the hypoglycemia treatment plan provided by your healthcare provider. If you are awake and able to swallow, a common approach is to take 15 grams of fast-acting glucose, recheck your blood sugar after 15 minutes, and repeat if necessary.
Seek emergency medical attention if someone experiences severe confusion, seizures, unconsciousness, or cannot safely swallow.
Contact your healthcare provider if your blood sugar remains consistently above or below your target range despite taking Glyset as prescribed.
You should also report persistent diarrhea, severe abdominal discomfort, or other digestive symptoms that do not improve.
Tell your healthcare provider if you develop kidney problems or begin taking additional diabetes medications, as your treatment plan may need adjustment.
Glyset helps control after-meal blood sugar when taken correctly and consistently. Taking the medication with the first bite of each main meal, following your prescribed dosage, monitoring blood glucose, and reporting persistent side effects can help support effective type 2 diabetes management.
Glyset (Miglitol) is available in the following forms and strength:
Before taking Glyset, tell your healthcare provider about any existing medical conditions, allergies, or medications you are taking.
Glyset is a prescription oral medication used to help control blood sugar levels in adults with type 2 diabetes. It belongs to a class of medications called alpha-glucosidase inhibitors, which slow carbohydrate digestion and reduce blood sugar spikes after meals.
Although Glyset helps manage blood glucose levels, it may cause digestive side effects and interact with certain medications. People with kidney disease, serious intestinal conditions, or a history of low blood sugar may require additional precautions.
Your healthcare provider will determine whether Glyset is appropriate based on your medical history, kidney function, blood sugar levels, and other diabetes treatments.
Do not take Glyset if you are allergic to miglitol or any of the inactive ingredients in the tablets.
An allergic reaction occurs when your immune system responds to a substance it considers harmful. Although allergic reactions to Glyset are uncommon, they can range from mild skin irritation to serious symptoms requiring immediate medical attention.
Possible signs of an allergic reaction include:
Tell your healthcare provider if you have experienced an allergic reaction to miglitol or similar medications.
Stop taking Glyset and contact your healthcare provider if you develop a suspected allergic reaction.
Seek emergency medical attention immediately if you experience difficulty breathing, swelling of your tongue or throat, or other symptoms of a severe allergic reaction.
Glyset commonly causes digestive side effects, particularly during the first few weeks of treatment.
Miglitol works by slowing the breakdown of carbohydrates in the small intestine. This allows some carbohydrates to reach the large intestine before they are fully digested.
Bacteria in the large intestine break down these carbohydrates through a process called fermentation, which can produce gas and cause digestive discomfort.
Common gastrointestinal side effects include:
These symptoms may become less noticeable as your body adjusts to the medication.
However, Glyset should not be used by people with certain serious intestinal conditions, including inflammatory bowel disease, colonic ulceration, intestinal obstruction, or conditions that increase the risk of intestinal blockage.
It is also unsuitable for people with chronic intestinal diseases that significantly interfere with digestion or nutrient absorption, or conditions that could become worse because of increased intestinal gas.
Tell your healthcare provider if you have Crohn’s disease, ulcerative colitis, intestinal obstruction, or a history of significant digestive problems.
Contact your healthcare provider if you experience persistent diarrhea, severe bloating, or worsening abdominal pain.
Seek urgent medical attention if you develop severe abdominal pain, repeated vomiting, or an inability to pass stool or gas.
Glyset should be used with caution in people with kidney disease or reduced kidney function.
The kidneys help remove miglitol from the bloodstream.
When kidney function is impaired, the medication may remain in the body longer and reach higher blood concentrations.
People with significant kidney impairment may therefore have increased exposure to miglitol.
Glyset is generally not recommended for patients with a creatinine clearance below 25 mL/min because there is limited information about its safety in this population.
Creatinine clearance measures how effectively the kidneys filter waste products from the blood.
Your healthcare provider may recommend kidney function tests before starting Glyset and periodically during treatment.
Tell your healthcare provider if you have chronic kidney disease, reduced kidney function, or a history of kidney problems.
Do not adjust your Glyset dosage without medical advice.Â
Tell your healthcare provider if you have liver disease or a history of abnormal liver function before taking Glyset.
Unlike some other diabetes medications, miglitol is not significantly metabolized by the liver.
Instead, the medication is primarily eliminated through the kidneys.
Clinical studies have not shown meaningful changes in miglitol processing in people with liver cirrhosis compared with people who have normal liver function.
Therefore, liver disease alone does not generally require a dosage adjustment.
However, serious liver conditions may affect overall blood sugar regulation, nutrition, and the body’s response to diabetes medications.
Your healthcare provider should review your medical history and determine whether additional monitoring is necessary.
Do not stop taking Glyset or change your dosage without consulting your healthcare provider.Â
Glyset generally has a low risk of causing hypoglycemia when taken alone because it does not directly stimulate insulin production.
However, the risk of low blood sugar may increase when Glyset is combined with insulin or certain other diabetes medications, particularly sulfonylureas.
Hypoglycemia occurs when blood glucose levels fall below the normal range, commonly defined as less than 70 mg/dL (3.9 mmol/L).
Possible symptoms include:
If you experience low blood sugar while taking Glyset, use glucose (dextrose) rather than ordinary table sugar (sucrose) to raise your blood glucose.
Glyset slows the breakdown of sucrose into absorbable sugars, which may delay its ability to correct hypoglycemia.
Glucose tablets or glucose gel containing dextrose are more suitable because glucose does not require the same digestive breakdown.
If you are awake and able to swallow, follow your healthcare provider’s hypoglycemia treatment plan. A common approach is to take 15 grams of fast-acting glucose, recheck your blood sugar after 15 minutes, and repeat if necessary.
Severe hypoglycemia may require glucagon or emergency medical treatment.
Seek emergency medical attention if someone becomes unconscious, experiences seizures, or cannot safely swallow.
Your healthcare provider may need to adjust your insulin or sulfonylurea dosage if repeated episodes of low blood sugar occur.Â
Tell your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding before taking Glyset.
Managing blood sugar during pregnancy is important because uncontrolled diabetes may increase the risk of complications affecting both the pregnant person and the developing baby.
There is limited information about the safety of miglitol during human pregnancy.
Although animal studies have not established the same risks as those seen with some other medications, available human data are insufficient to confirm that Glyset is safe during pregnancy.
Your healthcare provider may recommend a diabetes treatment with more established pregnancy safety information, such as insulin.
Glyset is also not generally recommended during breastfeeding because limited information is available about its effects on breastfed infants.
Small amounts of miglitol have been detected in human breast milk, but the clinical significance remains uncertain.
If you become pregnant while taking Glyset, contact your healthcare provider promptly to review your treatment plan.
Do not stop your diabetes treatment without medical advice, as uncontrolled blood sugar may also cause health complications.
Glyset is indicated for adults with type 2 diabetes and is not approved for treating type 1 diabetes.
Type 1 diabetes occurs when the pancreas produces little or no insulin because the body’s immune system destroys insulin-producing cells.
People with type 1 diabetes require insulin treatment to regulate blood sugar and prevent serious complications.
Glyset does not replace insulin and should not be used as an alternative to essential insulin therapy.
Glyset is also contraindicated in people with diabetic ketoacidosis (DKA).
Diabetic ketoacidosis is a serious condition that develops when the body does not have enough insulin and begins breaking down fat rapidly for energy.
This process produces substances called ketones, which can build up in the bloodstream and make the blood dangerously acidic.
Possible symptoms include:
DKA requires emergency medical treatment, typically involving insulin, intravenous fluids, and electrolyte replacement.
Glyset must not be used to treat diabetic ketoacidosis. Seek emergency medical attention if you develop symptoms suggesting this condition.Â
Tell your healthcare provider if you are scheduled for surgery, a colonoscopy, or another medical procedure while taking Glyset.
Medical procedures may require changes to your usual eating schedule, fluid intake, or diabetes treatment.
For example, a colonoscopy often involves temporary dietary restrictions and bowel preparation.
Because Glyset works by slowing carbohydrate digestion during meals, its usual dosing schedule may not be appropriate when you are fasting or following a restricted diet.
Surgery, infection, fever, and physical stress can also affect blood sugar levels.
In some cases, your healthcare provider may recommend temporarily changing your diabetes medications or using insulin to maintain appropriate glucose control.
Do not take Glyset with a missed meal unless your healthcare provider has specifically instructed you to do so.
Before any procedure, tell your healthcare team about all diabetes medications you take.
Follow the instructions provided for fasting, blood glucose monitoring, and medication adjustments.
Glyset may interact with certain medications and supplements, potentially affecting how well your treatment works or increasing your risk of side effects.
Some medications may change blood glucose levels, while others may affect the absorption or effectiveness of miglitol.
Medications that may require special consideration include:
Tell your healthcare provider if you take dalteparin or another anticoagulant, particularly if you have additional medical conditions or are undergoing a procedure. However, dalteparin is not a specifically established interaction in the standard Glyset prescribing information.
Not every medication combination will cause a clinically significant interaction.
Your healthcare provider or pharmacist can review your medication list and determine whether dosage adjustments or additional monitoring are necessary.
Do not start, stop, or change another medication without medical advice.Â
Glyset may cause diarrhea, especially when treatment is first started or the dosage is increased.
Frequent loose bowel movements can cause the body to lose water and electrolytes.
If fluid loss is significant and not replaced, dehydration may develop.
Possible symptoms of dehydration include:
Drink enough fluids throughout the day unless your healthcare provider has recommended restricting your fluid intake.
If diarrhea becomes persistent, severe, or is accompanied by vomiting, contact your healthcare provider.
Dehydration may be especially concerning for people with diabetes and existing kidney problems.
Seek urgent medical attention if you experience severe dizziness, confusion, very little urine output, or an inability to keep fluids down.
Older adults may require additional monitoring while taking Glyset, particularly if they have reduced kidney function or take several medications.
Kidney function often declines with age, which may affect how efficiently the body removes miglitol.
Because Glyset is eliminated mainly through the kidneys, reduced kidney function can increase medication exposure.
Older adults may also have other health conditions or take medications that increase the risk of hypoglycemia.
However, age alone does not automatically require a lower Glyset dosage.
Your healthcare provider will consider your kidney function, blood sugar levels, overall health, and response to treatment before recommending a dosage.
Regular blood glucose monitoring and periodic medication reviews can help support safe treatment.
Contact your healthcare provider if you experience persistent diarrhea, severe abdominal discomfort, repeated episodes of low blood sugar, or blood glucose readings that remain outside your target range.
You should also report changes in kidney function, new medications, or digestive symptoms that become worse during treatment.
Seek urgent medical attention if you develop severe abdominal pain, repeated vomiting, or significant dehydration.
Seek emergency medical attention if you experience severe hypoglycemia, symptoms of diabetic ketoacidosis, difficulty breathing, or swelling of your face or throat.
Glyset can help manage type 2 diabetes by reducing blood sugar spikes after meals, but careful use is important. Following your prescribed dosage, monitoring blood glucose, recognizing digestive side effects, and reporting medication interactions can help reduce treatment-related complications.
Glyset begins working with the meal during which it is taken. The medication helps control blood sugar levels by slowing the breakdown of carbohydrates in the small intestine. When you eat foods containing carbohydrates, your digestive system breaks them down into smaller sugars, including glucose. These sugars are then absorbed into the bloodstream, causing blood sugar levels to rise. Glyset belongs to a class of medications called alpha-glucosidase inhibitors. It works by blocking certain digestive enzymes that break down carbohydrates into absorbable sugars. This slows carbohydrate digestion and helps reduce blood sugar spikes after meals. Because Glyset works during digestion, its effects on after-meal blood glucose may begin with the first dose. However, improvements in overall blood sugar control may take several weeks to become noticeable. Your healthcare provider may recommend regular blood glucose monitoring to determine how well the medication is working. Hemoglobin A1c (HbA1c) testing may also be used to assess your average blood sugar levels over approximately two to three months. The effectiveness of Glyset depends on your diet, prescribed dosage, blood sugar levels, and response to treatment. For the best results, take Glyset with the first bite of each main meal, exactly as directed by your healthcare provider.
No, Glyset is not approved for treating type 1 diabetes. It is primarily prescribed to help improve blood sugar control in adults with type 2 diabetes. Type 1 diabetes is a chronic autoimmune condition in which the immune system attacks the insulin-producing cells in the pancreas. As a result, the body produces little or no insulin. Insulin is essential for helping glucose move from the bloodstream into the body’s cells, where it can be used for energy. Without enough insulin, blood sugar levels can become dangerously high. Glyset works by slowing carbohydrate digestion and reducing the amount of glucose entering the bloodstream immediately after meals. However, it does not stimulate insulin production or replace the insulin the body needs. People with type 1 diabetes require insulin therapy to control blood sugar levels and prevent serious complications, including diabetic ketoacidosis. Although some medications that affect carbohydrate digestion have been studied as additional treatments for type 1 diabetes, Glyset is not an approved replacement for insulin therapy. Do not use Glyset instead of insulin or change your insulin dosage without medical advice. Your healthcare provider will recommend a treatment plan appropriate for your type of diabetes.
Yes, Glyset may be prescribed alongside other diabetes medications to improve blood sugar control in adults with type 2 diabetes. Glyset works differently from many other diabetes medications. Instead of directly increasing insulin production, it slows carbohydrate digestion in the small intestine, helping reduce blood sugar spikes after meals. Your healthcare provider may prescribe Glyset alongside medications such as metformin, insulin, or certain sulfonylureas when additional blood glucose control is needed. Metformin helps lower glucose production in the liver and improves the body’s response to insulin. Glyset primarily targets the rise in blood sugar that occurs after eating. Using medications with different mechanisms may help manage blood glucose levels more effectively. However, combining Glyset with insulin or sulfonylureas, such as glipizide or glimepiride, can increase the risk of hypoglycemia, also called low blood sugar. Symptoms of hypoglycemia may include shaking, sweating, dizziness, sudden hunger, weakness, and a rapid heartbeat. If low blood sugar occurs while taking Glyset, use glucose (dextrose) rather than ordinary table sugar (sucrose) to raise your blood sugar. Glyset slows the breakdown of sucrose, which may delay its ability to correct hypoglycemia. Your healthcare provider may recommend regular blood glucose monitoring or adjustments to your other diabetes medications to reduce the risk of low blood sugar. Before starting Glyset, tell your healthcare provider about all prescription medications, over-the-counter drugs, and supplements you take. Do not combine or change diabetes medications without medical advice.
If you miss a dose of Glyset, skip the missed dose and take your next scheduled dose with the first bite of your next main meal. Glyset is usually taken three times daily with breakfast, lunch, and dinner. The medication works by slowing carbohydrate digestion during meals, so taking it at the correct time is important for controlling after-meal blood sugar levels. If you remember that you missed a dose after finishing your meal, do not take the tablet later to make up for it. Taking Glyset after carbohydrate digestion has already started may reduce its effectiveness. Do not take two doses at once or increase your next dose to replace the missed tablet. Taking extra medication may increase the risk of digestive side effects, including abdominal pain, gas, bloating, and diarrhea. If you skip a meal, generally skip the Glyset dose associated with that meal unless your healthcare provider gives you different instructions. Continue monitoring your blood sugar as recommended, especially if you miss doses frequently or notice readings outside your target range. If you are unsure how to continue your medication schedule, contact your healthcare provider or pharmacist for advice. Taking Glyset consistently with the first bite of each main meal can help maintain better after-meal blood sugar control and support your overall diabetes management plan.
| Generic name: | Miglitol |
|---|---|
| Formulation: | Tablet |
| Strength(s): | 25mg, 50mg |
| Quantities Available: | 100 |
Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.
Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.
When ordering Glyset (miglitol) from a Canadian pharmacy, you can typically purchase up to a 90-day supply at one time, which is common for prescription medications to ensure adequate management of chronic conditions without frequent refills.
Here’s what you need to know:
Dosage and Quantity: Glyset is commonly prescribed in dosages of 25 mg or 50 mg, typically taken three times daily with meals. For a 90-day supply, this means you would order 270 tablets (90 days x 3 tablets per day).
Yes, we sell miglitol on our website. You can enjoy low prices when you order through us. To purchase miglitol, you will need a valid prescription from your healthcare provider. We require this prescription to dispense the medication safely and appropriately. You can submit your prescription by mailing it to us, faxing it, or uploading it through your online account.
Yes, we ship Glyset (miglitol) to both the United States and Puerto Rico.
Watch how Online Pharmacies Canada is helping customers save money on their medications.
Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Glyset (Miglitol). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Glyset (Miglitol).
REVIEWS